热门资讯> 正文

Nuvalent股票发行3.5亿美元，股价上涨19%

2024-09-16 19:22

Nuvalent Inc Ordinary Shares - Class A(NUVL) 0

Clinical-stage biopharmaceutical company Nuvalent (NASDAQ:NUVL) commenced an underwritten public offering of $350M shares.
There can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
Underwriters have a 30-day option to purchase up to an additional 15% of the shares.
Shares of Nuvalent (NUVL) jumped 19% to $104 on Monday during pre-market hours of trade.

More on Nuvalent

Nuvalent: Making Precise Progress In Its Oncology Pipeline
Seeking Alpha’s Quant Rating on Nuvalent
Historical earnings data for Nuvalent
Financial information for Nuvalent

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。